Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Avadel Pharmaceuticals PLC (AD - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AVDL
Nasdaq
2834
https://www.avadel.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Avadel Pharmaceuticals PLC (AD
Avadel's stock falls 21% after disclosing new FDA request for experimental narcolepsy drug
- May 26th, 2022 1:09 pm
Avadel to Present Clinical Data for FT218 at SLEEP 2022
- May 19th, 2022 12:00 pm
Avadel Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
- May 18th, 2022 12:00 pm
What You Need To Know About Avadel Pharmaceuticals plc's (NASDAQ:AVDL) Investor Composition
- May 9th, 2022 2:05 pm
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
- May 9th, 2022 11:00 am
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9
- May 2nd, 2022 12:00 pm
Martello Announces Appointment of Jim Clark as Chief Financial Officer
- Apr 28th, 2022 12:00 pm
Why Avadel Pharmaceuticals Stock Is Skyrocketing Today
- Apr 26th, 2022 3:38 pm
Avadel Pharmaceuticals Provides Comment on Recent Trading Activity
- Apr 26th, 2022 11:30 am
Avadel Pharmaceuticals Announces Interim Data from the Open-Label RESTORE Study at the 2022 American Academy of Neurology Annual Meeting
- Apr 25th, 2022 12:00 pm
Avadel Pharmaceuticals Announces Publication of Positive Secondary Endpoint Data from Pivotal Phase 3 REST-ON Trial
- Apr 6th, 2022 12:00 pm
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
- Mar 22nd, 2022 12:00 pm
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
- Mar 17th, 2022 11:00 am
Avadel Pharmaceuticals Announces Appointment of Brandi Robinson as Senior Vice President, Corporate Affairs
- Mar 14th, 2022 8:30 pm
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 17th
- Mar 14th, 2022 12:00 pm
Avadel Announces New Positive Data for Once-at-Bedtime FT218 for Narcolepsy and Once-Nightly Dosing Preference Among Patients and Clinicians at World Sleep 2022
- Mar 11th, 2022 12:00 pm
Avadel Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference
- Mar 10th, 2022 9:30 pm
Avadel to Present New Clinical Data at World Sleep 2022
- Mar 1st, 2022 12:00 pm
Is Avadel Pharmaceuticals (NASDAQ:AVDL) A Risky Investment?
- Feb 22nd, 2022 4:40 pm
Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer
- Feb 14th, 2022 12:00 pm
Scroll